Continuous inhibition of epidermal growth factor receptor phosphorylation by erlotinib enhances antitumor activity of chemotherapy in erlotinib-resistant tumor xenografts

por IWAI, TOSHIKI, MORIYA, YOICHIRO, SHIRANE, MASATOSHI, FUJIMOTO-OUCHI, KAORI, MORI, KAZUSHIGE
Publicado 2011

Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6–producing lung carcinoma cells

por Noguchi-Sasaki, Mariko, Sasaki, Yusuke, Shimonaka, Yasushi, Mori, Kazushige, Fujimoto-Ouchi, Kaori
Publicado 2016

Biomarkers for antitumor activity of bevacizumab in gastric cancer models

por Yamashita-Kashima, Yoriko, Fujimoto-Ouchi, Kaori, Yorozu, Keigo, Kurasawa, Mitsue, Yanagisawa, Mieko, Yasuno, Hideyuki, Mori, Kazushige
Publicado 2012

Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization

por Yamashita-Kashima, Yoriko, Shu, Sei, Yorozu, Keigo, Hashizume, Kaoru, Moriya, Yoichiro, Fujimoto-Ouchi, Kaori, Harada, Naoki
Publicado 2014

Erratum to: Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization

por Yamashita-Kashima, Yoriko, Shu, Sei, Yorozu, Keigo, Hashizume, Kaoru, Moriya, Yoichiro, Fujimoto-Ouchi, Kaori, Harada, Naoki
Publicado 2014

Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro

por Noguchi-Sasaki, Mariko, Soeda, Tetsuhiro, Ueyama, Atsunori, Muto, Atsushi, Hirata, Michinori, Kitamura, Hidetomo, Fujimoto-Ouchi, Kaori, Kawabe, Yoshiki, Nogami, Keiji, Shima, Midori, Kitazawa, Takehisa
Publicado 2018